Media-OutReach Newswire HKU AIDS Institute & Immuno Cure’s Collaborative Therapeutic HIV Vaccine Research Project secured HK$66.7m TRS funding from Research Grant Council
Society Investment in healthcare services necessary for enhancing quality of life in marginalised regions